Entegris, Inc. — Q3 2012 Form 10-Q
Business context and reporting period. Entegris supplies products and services that purify, protect, and transport materials used mainly in semiconductor and related high-technology manufacturing. This unaudited filing covers the three and nine months ended September 29, 2012; comparisons are with the periods ended October 1, 2011, unless noted. Amounts below are in U.S. dollars.
Financial performance
- Q3 revenue: $184.4 million, up 7% year over year, but down 2% sequentially from Q2 2012. Foreign currency reduced year-over-year growth by $4.8 million; excluding that effect, sales rose 9%.
- Nine-month revenue: $548.1 million, down 6% year over year (down 5% excluding $8.3 million of unfavorable currency translation). Management attributed the decline mainly to reduced semiconductor-industry capital spending that began in the second half of 2011.
- Profit and margins: Q3 gross profit was $81.9 million, with a 44.4% gross margin versus 43.2% a year earlier. Operating income was $27.1 million (14.7% margin), compared with $26.8 million (15.5%). Net income attributable to Entegris was $18.0 million, or $0.13 per diluted share, versus $22.0 million, or $0.16. For nine months, operating income was $85.5 million versus $105.2 million; net income was $57.6 million, or $0.42 per diluted share, versus $83.7 million, or $0.62.
- Expenses and taxes: Q3 SG&A rose 17% to $39.1 million; it includes a $3.9 million CEO transition compensation charge. The effective tax rate was 32.2% in 2012 versus 21.2% in 2011; the prior-year rate benefited from a $14.9 million valuation-allowance release.
- Cash flow: Nine-month operating cash flow was $76.8 million, down from $112.8 million. Capital expenditures were $39.1 million, versus $24.1 million in the prior-year period. Cash and cash equivalents increased to $307.8 million; cash, cash equivalents, and short-term investments totaled $315.8 million.
- Liquidity and debt: Working capital was $467.9 million, up from $410.4 million at year-end 2011. The company reported no short- or long-term debt and no borrowings under its $30 million revolving facility; $0.2 million of letters of credit was outstanding. It was in compliance with facility covenants.
Material changes and business drivers
- Q3 unit-driven sales increased 8% year over year and represented 66% of sales; capital-driven sales increased 1% and represented 34%. Sequentially, both categories softened.
- Contamination Control Solutions: Q3 sales rose 3% to $112.9 million, while segment profit fell to $27.2 million from $29.5 million. Nine-month sales and segment profit declined 7% and 18%, respectively.
- Microenvironments: Q3 sales rose 27% to $54.4 million and segment profit increased to $16.8 million from $6.8 million. Results benefited from 300mm products and royalty revenue, including $2.6 million of one-time upfront license fees. Nine-month sales were down 2%, while segment profit rose to $30.8 million.
- Specialty Materials: Q3 sales fell 15% to $17.2 million and segment profit fell to $2.1 million from $4.7 million. Nine-month sales and segment profit declined 12% and 20%, respectively.
- Q3 adjusted EBITDA, a non-GAAP measure, increased 15% to $40.8 million (22.1% margin); adjusted operating income rose 17% to $33.5 million (18.1% margin). Nine-month adjusted EBITDA fell 11% to $117.6 million and non-GAAP EPS fell 28% to $0.46. These measures exclude specified items and are not GAAP results.
Outlook, management commentary, and risks
- Management expected 2012 capital expenditures of approximately $50–$60 million; the credit facility limits annual capital expenditures to $85 million. Management said it expected available cash, investments, credit facilities, and operating cash flow to meet working-capital and investment needs for the next 12 months.
- The filing gives no specific revenue or earnings forecast. Management cited semiconductor cyclicality, customer capital spending and utilization, pricing and competition, product mix, raw-material costs, manufacturing utilization, and foreign exchange as factors affecting results.
- In September 2012, the board announced a CEO succession plan: Bertrand Loy was to become president effective November 1 and CEO on November 27, succeeding Gideon Argov. The company recorded a $3.9 million pretax compensation charge in Q3 in connection with the transition.
- On April 2, 2012, Entegris acquired the remaining 50% of its Taiwan EPT investee for $3.4 million cash, bringing ownership to 100%. The company recognized a $1.3 million gain on remeasurement of its prior interest; EPT’s results were described as immaterial.
- Q3 other expense included $1.5 million of foreign-currency transaction losses, mainly from remeasurement of yen-denominated assets and liabilities. A 100-basis-point interest-rate change was estimated to affect annual net income by approximately $2.0 million. The company reported no net exposure to foreign-exchange forward contracts at quarter-end.
- The company said ordinary-course legal claims were not expected to have a material adverse effect. Management reported effective disclosure controls and no material change in internal control over financial reporting during the quarter.
Important facts for investors to verify
- Whether semiconductor demand and capital spending improved or weakened after quarter-end, particularly given the sequential sales decline and nine-month revenue contraction.
- Whether Q3 margin and Microenvironments profit gains are sustainable apart from royalty income and one-time license fees, and how segment performance develops.
- How the $3.9 million CEO transition charge, tax-rate normalization, and currency effects influence subsequent GAAP earnings and cash generation.
- Whether capital expenditures remain within the $50–$60 million plan and how inventory growth affects working capital and operating cash flow.
- That adjusted EBITDA, adjusted operating income, and non-GAAP EPS are management-defined measures; review their reconciliations and the corresponding GAAP results.